# IP Strategy Holdings, Inc.: financial statements, quarterly

IPST · Nasdaq · CIK 1788230 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ipst.md) · [Financials](/companies/ipst/financials.md) · [Filings](/companies/ipst/filings.md) · [Insiders](/companies/ipst/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ipst/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2.1](/filings/0001213900-24-113078.md) | [2.4 d](/filings/0001788230-25-000048.md) | [1.7](/filings/0001788230-25-000062.md) | [1.8](/filings/0001788230-25-000126.md) | [1.8](/filings/0001788230-25-000175.md) | [3.1 d](/filings/0001788230-26-000046.md) | [1.1](/filings/0001788230-26-000068.md) | [1.3](/filings/0001788230-26-000085.md) | [3.0](/filings/0001788230-25-000175.md) | [4.7 d](/filings/0001788230-26-000046.md) | [1.7](/filings/0001788230-26-000068.md) | [0.7](/filings/0001788230-26-000085.md) |
| Cost of revenue | $m | [1.4](/filings/0001213900-24-113078.md) | [(3.9) d](/filings/0001788230-25-000048.md) | [0.0](/filings/0001788230-25-000062.md) | [0.0](/filings/0001788230-25-000126.md) | [1.1](/filings/0001788230-25-000175.md) | [2.8 d](/filings/0001788230-26-000046.md) | [0.8](/filings/0001788230-26-000068.md) | [1.1](/filings/0001788230-26-000085.md) | [1.2](/filings/0001788230-25-000175.md) | [1.5 d](/filings/0001788230-26-000046.md) | [0.5](/filings/0001788230-26-000068.md) | [0.3](/filings/0001788230-26-000085.md) |
| Gross profit | $m | [0.7](/filings/0001213900-24-113078.md) | [0.8 d](/filings/0001788230-25-000048.md) | [0.4](/filings/0001788230-25-000062.md) | [0.7](/filings/0001788230-25-000126.md) | [0.6](/filings/0001788230-25-000175.md) | [0.3 d](/filings/0001788230-26-000046.md) | [0.3](/filings/0001788230-26-000068.md) | [0.2](/filings/0001788230-26-000085.md) | [1.8](/filings/0001788230-25-000175.md) | [3.2 d](/filings/0001788230-26-000046.md) | [1.2](/filings/0001788230-26-000068.md) | [0.4](/filings/0001788230-26-000085.md) |
| Operating income | $m | [(2.1)](/filings/0001213900-24-113078.md) | [(2.1) d](/filings/0001788230-25-000048.md) | [(2.2)](/filings/0001788230-25-000062.md) | [(2.3)](/filings/0001788230-25-000126.md) | [(2.1)](/filings/0001788230-25-000175.md) | [(8.3) d](/filings/0001788230-26-000046.md) | [(2.5)](/filings/0001788230-26-000068.md) | [(6.6)](/filings/0001788230-26-000085.md) | [(1.1)](/filings/0001788230-25-000175.md) | [(124) d](/filings/0001788230-26-000046.md) | [(66.4)](/filings/0001788230-26-000068.md) | [(14.8)](/filings/0001788230-26-000085.md) |
| Interest expense | $m | not reported | not reported | [0.6](/filings/0001788230-25-000062.md) | [0.6](/filings/0001788230-25-000126.md) | not reported | not reported | [0.5](/filings/0001788230-26-000068.md) | [0.6](/filings/0001788230-26-000085.md) | not reported | not reported | [0.0](/filings/0001788230-26-000068.md) | [0.0](/filings/0001788230-26-000085.md) |
| Income tax | $m | not reported | not reported | not reported | [0.0](/filings/0001788230-25-000126.md) | [0.0](/filings/0001788230-25-000175.md) | [0.0 d](/filings/0001788230-26-000046.md) | [0.0](/filings/0001788230-26-000068.md) | [0.0](/filings/0001788230-26-000085.md) | [49.4](/filings/0001788230-25-000175.md) | [(49.4) d](/filings/0001788230-26-000046.md) | [0.0](/filings/0001788230-26-000068.md) | [0.0](/filings/0001788230-26-000085.md) |
| Net income | $m | [(3.4)](/filings/0001213900-24-113078.md) | [(5.2) d](/filings/0001788230-25-000048.md) | [0.5](/filings/0001788230-25-000062.md) | [8.4](/filings/0001788230-25-000126.md) | [(3.4)](/filings/0001788230-25-000175.md) | [(4.7) d](/filings/0001788230-26-000046.md) | [(3.0)](/filings/0001788230-26-000068.md) | [(7.3)](/filings/0001788230-26-000085.md) | [196](/filings/0001788230-25-000175.md) | [(324) d](/filings/0001788230-26-000046.md) | [(66.7)](/filings/0001788230-26-000068.md) | [(15.4)](/filings/0001788230-26-000085.md) |
| Diluted EPS | $ per share | [(8.99)](/filings/0001213900-24-113078.md) | not reported | [0.13](/filings/0001788230-25-000062.md) | [1.29](/filings/0001788230-25-000126.md) | [(160.41)](/filings/0001788230-25-000175.md) | not reported | [(135.34)](/filings/0001788230-26-000068.md) | [(308.12)](/filings/0001788230-26-000085.md) | [16.97](/filings/0001788230-25-000175.md) | not reported | [(134.70)](/filings/0001788230-26-000068.md) | [(13.30)](/filings/0001788230-26-000085.md) |
| Basic EPS | $ per share | [(8.99)](/filings/0001213900-24-113078.md) | not reported | [1.12](/filings/0001788230-25-000062.md) | [19.90](/filings/0001788230-25-000126.md) | [(160.41)](/filings/0001788230-25-000175.md) | not reported | [(135.34)](/filings/0001788230-26-000068.md) | [(308.12)](/filings/0001788230-26-000085.md) | [16.97](/filings/0001788230-25-000175.md) | not reported | [(134.70)](/filings/0001788230-26-000068.md) | [(13.30)](/filings/0001788230-26-000085.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [0.1](/filings/0001788230-25-000048.md) | not reported | not reported | not reported | [0.5](/filings/0001788230-26-000046.md) | [0.1](/filings/0001788230-25-000062.md) | [0.2](/filings/0001788230-25-000126.md) | [1.7](/filings/0001788230-25-000175.md) | [0.2](/filings/0001788230-26-000085.md) | [0.1](/filings/0001788230-26-000068.md) | [0.0](/filings/0001788230-26-000085.md) |
| Current assets | $m | not reported | [5.3](/filings/0001788230-25-000048.md) | not reported | not reported | [5.9](/filings/0001213900-24-113078.md) | [3.9](/filings/0001788230-26-000046.md) | [3.2](/filings/0001788230-25-000062.md) | [3.1](/filings/0001788230-25-000126.md) | [4.9](/filings/0001788230-25-000175.md) | [2.7](/filings/0001788230-26-000085.md) | [3.8](/filings/0001788230-26-000068.md) | [3.1](/filings/0001788230-26-000085.md) |
| Total assets | $m | not reported | [26.3](/filings/0001788230-25-000048.md) | not reported | not reported | [31.1](/filings/0001213900-24-113078.md) | [28.0](/filings/0001788230-26-000046.md) | [27.1](/filings/0001788230-25-000062.md) | [26.5](/filings/0001788230-25-000126.md) | [483](/filings/0001788230-25-000175.md) | [109](/filings/0001788230-26-000085.md) | [42.8](/filings/0001788230-26-000068.md) | [29.6](/filings/0001788230-26-000085.md) |
| Current liabilities | $m | not reported | [62.8](/filings/0001788230-25-000048.md) | not reported | not reported | [46.5](/filings/0001213900-24-113078.md) | [13.8](/filings/0001788230-26-000046.md) | [13.9](/filings/0001788230-25-000062.md) | [16.4](/filings/0001788230-25-000126.md) | [10.4](/filings/0001788230-25-000175.md) | [8.9](/filings/0001788230-26-000085.md) | [8.8](/filings/0001788230-26-000068.md) | [9.8](/filings/0001788230-26-000085.md) |
| Total liabilities | $m | not reported | [69.7](/filings/0001788230-25-000048.md) | not reported | not reported | [65.1](/filings/0001213900-24-113078.md) | [27.2](/filings/0001788230-26-000046.md) | [27.4](/filings/0001788230-25-000062.md) | [29.4](/filings/0001788230-25-000126.md) | [62.3](/filings/0001788230-25-000175.md) | [10.5](/filings/0001788230-26-000085.md) | [10.4](/filings/0001788230-26-000068.md) | [11.3](/filings/0001788230-26-000085.md) |
| Long-term debt | $m | not reported | [14.3](/filings/0001788230-25-000048.md) | not reported | not reported | [15.0](/filings/0001213900-24-113078.md) | [13.2](/filings/0001788230-26-000046.md) | [13.0](/filings/0001788230-25-000062.md) | [13.0](/filings/0001788230-25-000126.md) | [2.6](/filings/0001788230-25-000175.md) | [2.6](/filings/0001788230-26-000085.md) | [2.6](/filings/0001788230-26-000068.md) | [2.5](/filings/0001788230-26-000085.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [(38.3)](/filings/0001213900-24-113078.md) | [(43.4)](/filings/0001788230-26-000046.md) | [(43.0)](/filings/0001788230-25-000126.md) | [(32.7)](/filings/0001788230-25-000175.md) | [(34.0)](/filings/0001788230-25-000175.md) | [0.8](/filings/0001788230-26-000085.md) | [(0.3)](/filings/0001788230-26-000085.md) | [(2.9)](/filings/0001788230-26-000085.md) | [420](/filings/0001788230-25-000175.md) | [98.2](/filings/0001788230-26-000085.md) | [32.4](/filings/0001788230-26-000085.md) | [18.3](/filings/0001788230-26-000085.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(2,412) d](/filings/0001788230-25-000048.md) | [(2,660)](/filings/0001788230-25-000062.md) | [(2,723) d](/filings/0001788230-25-000126.md) | [(845) d](/filings/0001788230-25-000175.md) | [(4,988) d](/filings/0001788230-26-000046.md) | [(2,031)](/filings/0001788230-26-000068.md) | [(698) d](/filings/0001788230-26-000085.md) | [(5,093) d](/filings/0001788230-25-000175.md) | [(7,507) d](/filings/0001788230-26-000046.md) | [(2,453)](/filings/0001788230-26-000068.md) | [(1,644) d](/filings/0001788230-26-000085.md) |
| Capital expenditure | $k | not reported | [0.0](/filings/0001788230-25-000062.md) | [292 d](/filings/0001788230-25-000126.md) | [(260) d](/filings/0001788230-25-000175.md) | [74.3 d](/filings/0001788230-26-000046.md) | [17.3](/filings/0001788230-26-000068.md) | [11.3 d](/filings/0001788230-26-000085.md) | [46.2 d](/filings/0001788230-25-000175.md) | [0.0 d](/filings/0001788230-26-000046.md) | [0.0](/filings/0001788230-26-000068.md) | [0.0 d](/filings/0001788230-26-000085.md) |
| Share repurchases | $k | [0.8 d](/filings/0001788230-25-000048.md) | not reported | not reported | [1.3 d](/filings/0001788230-25-000175.md) | [0.0 d](/filings/0001788230-26-000046.md) | not reported | not reported | [0.0 d](/filings/0001788230-25-000175.md) | [2.0 d](/filings/0001788230-26-000046.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.4](/filings/0001213900-24-113078.md) | [3.5](/filings/0001788230-25-000062.md) | [4.6](/filings/0001788230-25-000126.md) | [0.0](/filings/0001788230-25-000175.md) | [0.0](/filings/0001788230-26-000068.md) | [0.0](/filings/0001788230-26-000085.md) | [11.6](/filings/0001788230-25-000175.md) | [0.5](/filings/0001788230-26-000068.md) | [1.2](/filings/0001788230-26-000085.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 995,933 at 2026-10-22, from the cover of the [10-Q filed 2026-10-23](/filings/0001788230-26-000085.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.